82 FR 60407 - Proposed Collection; 60-Day Comment Request Division of Cancer Epidemiology and Genetics Fellowship Program and Summer Student Applications (DCEG) (National Cancer Institute)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 243 (December 20, 2017)

Page Range		60407-60408
FR Document		2017-27415

In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Cancer Institute (NCI) will publish periodic summaries of propose projects to be submitted to the Office of Management and Budget (OMB) for review and approval.

Federal Register, Volume 82 Issue 243 (Wednesday, December 20, 2017)

[Federal Register Volume 82, Number 243 (Wednesday, December 20, 2017)]
[Notices]
[Pages 60407-60408]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-27415]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed Collection; 60-Day Comment Request Division of Cancer 
Epidemiology and Genetics Fellowship Program and Summer Student 
Applications (DCEG) (National Cancer Institute)

AGENCY: National Institutes of Health.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the requirement of the Paperwork Reduction 
Act of 1995 to provide opportunity for public comment on proposed data 
collection projects, the National Cancer Institute (NCI) will publish 
periodic summaries of propose projects to be submitted to the Office of 
Management and Budget (OMB) for review and approval.

DATES: Comments regarding this information collection are best assured 
of having their full effect if received within 60 days of the date of 
this publication.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data 
collection plans and instruments, submit comments in writing, or 
request more information on the proposed project, contact: Jackie 
Lavigne, Ph.D., M.P.H., Chief, Office of Education, Division of Cancer 
Epidemiology and Genetics, 9609 Medical Center Drive, MSC, Bethesda, 
Maryland 20892 or call non-toll-free number 240.276.7237or Email your 
request, including your address to: [email protected]. Formal 
requests for additional plans and instruments must be requested in 
writing.

SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork 
Reduction Act of 1995 requires: Written comments and/or suggestions 
from the public and affected agencies are invited to address one or 
more of the following points: (1) Whether the proposed collection of 
information is necessary for the proper performance of the function of 
the agency, including whether the information will have practical 
utility; (2) The accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used; (3) Ways to enhance the quality, 
utility, and clarity of the information to be collected; and (4) Ways 
to minimize's the burden of the collection of information on those who 
are to respond, including the use of appropriate automated, electronic, 
mechanical, or other technological

[[Page 60408]]

collection techniques or other forms of information technology.
    Proposed Collection Title: Fellowship Program and Summer Student 
Applications 0925-0716, Exp., date 5/31/2018, Extension, National 
Cancer Institute (NCI), National Institutes of Health (NIH).
    Need and Use of Information Collection: This is a request for 
approval of an ``Extension'' for three years. The National Cancer 
Institute, Division of Cancer Epidemiology and Genetics (DCEG) Office 
of Education administers a variety of programs and initiatives to 
recruit pre-college through post-doctoral educational level individuals 
into the Intramural Research Program to facilitate their development 
into future biomedical scientists. DCEG trains post-doctoral, doctoral 
candidates, graduate and baccalaureate students, through full time 
fellowships, summer fellowships, and internships in preparation for 
research careers in cancer epidemiology and genetics. The proposed 
information collection involves brief online applications completed by 
applicants to the full time and the summer fellowship programs. Full-
time fellowships include: Full-time Equivalents (FTE) and non-FTE 
fellowships for US citizens, permanent residents and international 
fellows. These applications are essential to the administration of 
these training programs as they enable OE to determine the eligibility 
and quality of potential awardees; to assess their potential as future 
scientists; to determine where mutual research interests exist; and to 
make decisions regarding which applicants will be proposed and approved 
for traineeship awards. In each case, completing the application is 
voluntary, but in order to receive due consideration, the prospective 
trainee is encouraged to complete all relevant fields. The information 
is for internal use to make decisions about prospective fellows and 
students that could benefit from the DCEG program.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 218 hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average  time
               Type of respondent                    Number of     responses per   per  response   Total  annual
                                                    respondents     respondent      (in hours)     burden  hour
----------------------------------------------------------------------------------------------------------------
Full-time Fellows...............................             150               1           30/60              75
Summer Students.................................             430               1           20/60             143
                                                 ---------------------------------------------------------------
    Total.......................................             580             580  ..............             218
----------------------------------------------------------------------------------------------------------------


    Dated: December 4, 2017.
Karla Bailey,
Project Clearance Liaison, National Cancer Institute, National 
Institutes of Health.
[FR Doc. 2017-27415 Filed 12-19-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 243 / Wednesday, December 20, 2017 / Notices 60407

immunotherapy using autologous (meaning DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND
one individual is both the donor and the HUMAN SERVICES HUMAN SERVICES
recipient) T cells transfected with a retroviral
vector (including lentiviral vectors), wherein National Institutes of Health National Institutes of Health
the vector expresses a CAR having:
(1) a single antigen specificity; and National Institute of Neurological Proposed Collection; 60-Day Comment
(2) comprising at least: Request Division of Cancer
(a) the complementary determining region
Disorders and Stroke Notice of Closed
Meetings Epidemiology and Genetics Fellowship
(CDR) sequences of the anti-CD30 antibody
known as 5F11; and Program and Summer Student
(b) a T cell signaling domain; Pursuant to section 10(d) of the Applications (DCEG) (National Cancer
for the prophylaxis and treatment of CD30- Federal Advisory Committee Act, as Institute)
expressing human cancers.’’ amended, notice is hereby given of the AGENCY: National Institutes of Health.
following meetings.
This technology discloses the ACTION: Notice.
The meetings will be closed to the
development of chimeric antigen public in accordance with the SUMMARY: In compliance with the
receptors that recognize the CD30 provisions set forth in sections requirement of the Paperwork
protein (also known as tumor necrosis 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Reduction Act of 1995 to provide
factor receptor superfamily member 8 as amended. The grant applications and opportunity for public comment on
(TNFRSF8)). CD30 is expressed on the the discussions could disclose proposed data collection projects, the
cell surface of several rare forms of confidential trade secrets or commercial National Cancer Institute (NCI) will
cancer, including Hodgkin lymphoma property such as patentable material, publish periodic summaries of propose
(HL), Non-Hodgkin’s Lymphoma (NHL), and personal information concerning projects to be submitted to the Office of
diffuse large B cell lymphoma (DLBCL), individuals associated with the grant Management and Budget (OMB) for
peripheral T cell lymphoma not applications, the disclosure of which review and approval.
otherwise specified (PTCL–NOS), would constitute a clearly unwarranted DATES: Comments regarding this
anaplastic large cell lymphoma (ALCL), invasion of personal privacy. information collection are best assured
and angioimmunoblastic T cell of having their full effect if received
lymphoma (AITL). The development of Name of Committee: National Institute of
Neurological Disorders and Stroke
within 60 days of the date of this
a new therapeutic targeting CD30 will publication.
benefit public health by offering up a Technologies for Large-Scale Recording and
Modulation in the Nervous System. FOR FURTHER INFORMATION CONTACT: To
treatment for these rare cancers in
Date: January 18–19, 2018. obtain a copy of the data collection
instances when conventional first line Time: 8:00 a.m. to 2:00 p.m. plans and instruments, submit
therapies are ineffective. Agenda: To review and evaluate grant comments in writing, or request more
This notice is made in accordance applications. information on the proposed project,
with 35 U.S.C. 209 and 37 CFR part 404. Place: Hilton Alexandria Old Town, 1767 contact: Jackie Lavigne, Ph.D., M.P.H.,
The prospective exclusive license will King Street, Alexandria, VA 22314. Chief, Office of Education, Division of
be royalty bearing, and the prospective Contact Person: Ernest Lyons, Ph.D., Cancer Epidemiology and Genetics,
exclusive license may be granted unless Scientific Review Officer; Scientific Review
9609 Medical Center Drive, MSC,
within fifteen (15) days from the date of Branch; NINDS/NIH/DHHS; Neuroscience
Bethesda, Maryland 20892 or call non-
this published notice, the National Center; 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529; 301–
toll-free number 240.276.7237or Email
Cancer Institute receives written your request, including your address to:
496–4056; lyonse@ninds.nih.gov.
evidence and argument that establishes lavignej@mail.nih.gov. Formal requests
that the grant of the license would not Name of Committee: Neurological Sciences
for additional plans and instruments
Training Initial Review Group; NST–1
be consistent with the requirements of must be requested in writing.
Subcommittee.
35 U.S.C. 209 and 37 CFR part 404. SUPPLEMENTARY INFORMATION: Section
Date: January 29–30, 2018.
In response to this Notice, the public Time: 8:00 a.m. to 6:00 p.m. 3506(c)(2)(A) of the Paperwork
may file comments or objections. Agenda: To review and evaluate grant Reduction Act of 1995 requires: Written
Comments and objections, other than applications. comments and/or suggestions from the
those in the form of a completed license Place: Hilton Alexandria Old Town, 1767 public and affected agencies are invited
application, will not be treated King Street, Alexandria, VA 22314. to address one or more of the following
confidentially, and may be made Contact Person: William Benzing, Ph.D., points: (1) Whether the proposed
publicly available. Scientific Review Officer, Scientific Review collection of information is necessary
Branch, NINDS/NIH/DHHS, Neuroscience for the proper performance of the
License applications submitted in Center, 6001 Executive Blvd., Suite 3204,
response to this Notice will be function of the agency, including
MSC 9529, Bethesda, MD 20892–9529, 301–
presumed to contain business whether the information will have
496–0660, benzingw@mail.nih.gov.
confidential information and any release practical utility; (2) The accuracy of the
(Catalogue of Federal Domestic Assistance agency’s estimate of the burden of the
of information in these license Program Nos. 93.853, Clinical Research
applications will be made only as proposed collection of information,
Related to Neurological Disorders; 93.854,
required and upon a request under the Biological Basis Research in the
including the validity of the
Freedom of Information Act, 5 U.S.C. Neurosciences, National Institutes of Health, methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
sradovich on DSK3GMQ082PROD with NOTICES

552. HHS)
clarity of the information to be
Dated: December 8, 2017. Dated: December 14, 2017. collected; and (4) Ways to minimize’s
Richard U. Rodriguez, Sylvia L. Neal, the burden of the collection of
Associate Director, Technology Transfer Program Analyst, Office of Federal Advisory information on those who are to
Center, National Cancer Institute. Committee Policy. respond, including the use of
[FR Doc. 2017–27416 Filed 12–19–17; 8:45 am] [FR Doc. 2017–27329 Filed 12–19–17; 8:45 am] appropriate automated, electronic,
BILLING CODE 4140–01–P BILLING CODE 4140–01–P mechanical, or other technological

VerDate Sep<11>2014 21:36 Dec 19, 2017 Jkt 244001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\20DEN1.SGM 20DEN1

60408 Federal Register / Vol. 82, No. 243 / Wednesday, December 20, 2017 / Notices

collection techniques or other forms of doctoral, doctoral candidates, graduate potential as future scientists; to
information technology. and baccalaureate students, through full determine where mutual research
Proposed Collection Title: Fellowship time fellowships, summer fellowships, interests exist; and to make decisions
Program and Summer Student and internships in preparation for regarding which applicants will be
Applications 0925–0716, Exp., date 5/ research careers in cancer epidemiology proposed and approved for traineeship
31/2018, Extension, National Cancer and genetics. The proposed information awards. In each case, completing the
Institute (NCI), National Institutes of collection involves brief online application is voluntary, but in order to
Health (NIH). applications completed by applicants to receive due consideration, the
Need and Use of Information prospective trainee is encouraged to
Collection: This is a request for approval the full time and the summer fellowship
programs. Full-time fellowships complete all relevant fields. The
of an ‘‘Extension’’ for three years. The
include: Full-time Equivalents (FTE) information is for internal use to make
National Cancer Institute, Division of
and non-FTE fellowships for US decisions about prospective fellows and
Cancer Epidemiology and Genetics
(DCEG) Office of Education administers citizens, permanent residents and students that could benefit from the
a variety of programs and initiatives to international fellows. These DCEG program.
recruit pre-college through post-doctoral applications are essential to the OMB approval is requested for 3
educational level individuals into the administration of these training years. There are no costs to respondents
Intramural Research Program to programs as they enable OE to other than their time. The total
facilitate their development into future determine the eligibility and quality of estimated annualized burden hours are
biomedical scientists. DCEG trains post- potential awardees; to assess their 218 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Average Total
Number of
Number of time per annual
Type of respondent responses per
respondents response burden
respondent (in hours) hour

Full-time Fellows .............................................................................................. 150 1 30/60 75
Summer Students ............................................................................................ 430 1 20/60 143

Total .......................................................................................................... 580 580 ........................ 218

Dated: December 4, 2017. indicated licensing contact at the cells in situ, providing advantages to
Karla Bailey, Technology Transfer and Intellectual phenotyping cells with flow cytometric
Project Clearance Liaison, National Cancer Property Office, National Institute of techniques.
Institute, National Institutes of Health. Allergy and Infectious Diseases, 5601 This technology is available for
[FR Doc. 2017–27415 Filed 12–19–17; 8:45 am] Fishers Lane, Rockville, MD 20852; tel. licensing for commercial development
BILLING CODE 4140–01–P 301–496–2644. A signed Confidential in accordance with 35 U.S.C. 209 and 37
Disclosure Agreement will be required CFR part 404, as well as for further
to receive copies of unpublished patent development and evaluation under a
DEPARTMENT OF HEALTH AND applications. research collaboration.
HUMAN SERVICES SUPPLEMENTARY INFORMATION: Potential Commercial Applications:
Technology description follows. • Research reagent—can be applied to
National Institutes of Health a variety of biological disciplines.
Enhanced Tissue Clearing Solution, • Diagnostic medical imaging
Government-Owned Inventions; Clearing-Enhanced 3D (Ce3D), reagent—characterization of disease
Availability for Licensing Compatible With Advanced state/condition.
Fluorescence Microscopy Imaging Competitive Advantages:
AGENCY: National Institutes of Health,
HHS. Description of Technology: NIH • Simple, quick and inexpensive
ACTION: Notice. immunologists have created a solution, procedure that has been extensively
Clearing-enhanced 3D (Ce3D), that can validated.
SUMMARY: The invention listed below is be used to make entire organs extremely • Generates excellent tissue
owned by an agency of the U.S. transparent. This allows the tissue to be transparency, resulting in high quality
Government and is available for imaged using advanced fluorescence images.
licensing to achieve expeditious microscopy techniques. Unlike current • Compatible with highly
commercialization of results of tissue clearing solutions, the Ce3D multiplexed staining/labeling
federally-funded research and tissue clearing solution is robustly techniques, including antibody-based
development. Foreign patent compatible with a variety of staining methods, fluorescently tagged reporter
applications are filed on selected methods, and preserves tissue proteins, and RNA–FISH.
inventions to extend market coverage morphology and reporter fluorescence. • Fluorescence is maintained in
for companies and may also be available Ce3D enabled microscopy provides
sradovich on DSK3GMQ082PROD with NOTICES

diverse fluorescent proteins and
for licensing. unprecedented insight into the spatial fluorophores.
FOR FURTHER INFORMATION CONTACT: Dr. organization of cells within intact • Enables quantitative analysis of
Natalie Greco, 301–761–7898; organs. Further, when Ce3D enabled tissue composition and cellular
Natalie.Greco@nih.gov. Licensing microscopy is coupled with multiplexed distribution in whole organs, and has
information and copies of the patent staining and a newly developed analysis advantages over flow cytometric
applications listed below may be pipeline, investigators are able to techniques.
obtained by communicating with the extensively characterize densely packed Development Stage:

VerDate Sep<11>2014 21:36 Dec 19, 2017 Jkt 244001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\20DEN1.SGM 20DEN1

Document Created: 2018-10-25 10:57:39
Document Modified: 2018-10-25 10:57:39

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Dates		Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication.
Contact		To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Jackie Lavigne, Ph.D., M.P.H., Chief, Office of Education, Division of Cancer Epidemiology and Genetics, 9609 Medical Center Drive, MSC, Bethesda, Maryland 20892 or call non-toll-free number 240.276.7237or Email your
FR Citation		82 FR 60407

82 FR 60407 - Proposed Collection; 60-Day Comment Request Division of Cancer Epidemiology and Genetics Fellowship Program and Summer Student Applications (DCEG) (National Cancer Institute)

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 243 (December 20, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health